- Junchao Dong
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Rohit A. Panchakshari
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Tingting Zhang
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School
† Present addresses: Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, New York 10016, USA (T.Z.); National Institute of Biological Sciences, Beijing 102206, Beijing, China (Y.Z.); Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, New York 11724, USA (Y.-J.H.); 121Bio, 700 Main Street, Cambridge, Massachusetts 02139, USA (M.G.).)
- Yu Zhang
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School
† Present addresses: Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, New York 10016, USA (T.Z.); National Institute of Biological Sciences, Beijing 102206, Beijing, China (Y.Z.); Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, New York 11724, USA (Y.-J.H.); 121Bio, 700 Main Street, Cambridge, Massachusetts 02139, USA (M.G.).)
- Jiazhi Hu
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Sabrina A. Volpi
(Boston Children’s Hospital and Joint Program in Transfusion Medicine, Harvard Medical School)
- Robin M. Meyers
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Yu-Jui Ho
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School
† Present addresses: Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, New York 10016, USA (T.Z.); National Institute of Biological Sciences, Beijing 102206, Beijing, China (Y.Z.); Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, New York 11724, USA (Y.-J.H.); 121Bio, 700 Main Street, Cambridge, Massachusetts 02139, USA (M.G.).)
- Zhou Du
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Davide F. Robbiani
(Howard Hughes Medical Institute, Laboratory of Molecular Immunology, The Rockefeller University)
- Feilong Meng
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)
- Monica Gostissa
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School
† Present addresses: Eli Lilly and Company, Alexandria Center for Life Sciences, 450 East 29th Street, New York, New York 10016, USA (T.Z.); National Institute of Biological Sciences, Beijing 102206, Beijing, China (Y.Z.); Cold Spring Harbor Laboratory, Watson School of Biological Sciences, Cold Spring Harbor, New York 11724, USA (Y.-J.H.); 121Bio, 700 Main Street, Cambridge, Massachusetts 02139, USA (M.G.).)
- Michel C. Nussenzweig
(Howard Hughes Medical Institute, Laboratory of Molecular Immunology, The Rockefeller University)
- John P. Manis
(Boston Children’s Hospital and Joint Program in Transfusion Medicine, Harvard Medical School)
- Frederick W. Alt
(Howard Hughes Medical Institute, Program in Cellular and Molecular Medicine, Boston Children’s Hospital, Harvard Medical School)